MassChallenge Startups Create Impact

2,928

Startups Accelerated

$8.6B

Funding Raised

$3.6B

Revenue Generated

186K+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
REMINISCIENCES SA
REMINISCIENCES SA

REMINISCIENCES SA exploits the crucial role of gut microbiota in human physiology and more specifically as we have discovered in Alzheimer's disease. There is no effective treatment for Alzheimer, despite 51 million patients in need. Our company develops 2 products: CerebralX, a symbiotic therapeutic treatment to restore altered gut microbiota and stop or delay Alzheimer's disease, and ReminiTest, a diagnostic based upon microbiota profiling.
REMINISCIENCES develops a symbiotic treatment and a companion diagnostic for Alzheimer's disease through targeting the gut microbiome

Connect with REMINISCIENCES SA

2017

2017 Finalist Switzerland

Sub industry

Diagnostics

Additional Industries
Health and Wellness
Healthcare
Therapeutics (Pharma / Biotech)

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.